1 Study Coverage
    1.1 Next-Generation Drug-Eluting Stent Product Introduction
    1.2 Market by Type
        1.2.1 Global Next-Generation Drug-Eluting Stent Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Cobalt Chromium
        1.2.3 Stainless Steel
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Next-Generation Drug-Eluting Stent Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Ambulatory Surgical Centers
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Next-Generation Drug-Eluting Stent Sales Estimates and Forecasts 2017-2028
    2.2 Global Next-Generation Drug-Eluting Stent Revenue Estimates and Forecasts 2017-2028
    2.3 Global Next-Generation Drug-Eluting Stent Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Next-Generation Drug-Eluting Stent Sales by Region
        2.4.1 Global Next-Generation Drug-Eluting Stent Sales by Region (2017-2022)
        2.4.2 Global Sales Next-Generation Drug-Eluting Stent by Region (2023-2028)
    2.5 Global Next-Generation Drug-Eluting Stent Revenue by Region
        2.5.1 Global Next-Generation Drug-Eluting Stent Revenue by Region (2017-2022)
        2.5.2 Global Next-Generation Drug-Eluting Stent Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Next-Generation Drug-Eluting Stent Sales by Manufacturers
        3.1.1 Global Top Next-Generation Drug-Eluting Stent Manufacturers by Sales (2017-2022)
        3.1.2 Global Next-Generation Drug-Eluting Stent Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Next-Generation Drug-Eluting Stent in 2021
    3.2 Global Next-Generation Drug-Eluting Stent Revenue by Manufacturers
        3.2.1 Global Next-Generation Drug-Eluting Stent Revenue by Manufacturers (2017-2022)
        3.2.2 Global Next-Generation Drug-Eluting Stent Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Next-Generation Drug-Eluting Stent Revenue in 2021
    3.3 Global Next-Generation Drug-Eluting Stent Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Next-Generation Drug-Eluting Stent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Next-Generation Drug-Eluting Stent Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Next-Generation Drug-Eluting Stent Sales by Type
        4.1.1 Global Next-Generation Drug-Eluting Stent Historical Sales by Type (2017-2022)
        4.1.2 Global Next-Generation Drug-Eluting Stent Forecasted Sales by Type (2023-2028)
        4.1.3 Global Next-Generation Drug-Eluting Stent Sales Market Share by Type (2017-2028)
    4.2 Global Next-Generation Drug-Eluting Stent Revenue by Type
        4.2.1 Global Next-Generation Drug-Eluting Stent Historical Revenue by Type (2017-2022)
        4.2.2 Global Next-Generation Drug-Eluting Stent Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Next-Generation Drug-Eluting Stent Revenue Market Share by Type (2017-2028)
    4.3 Global Next-Generation Drug-Eluting Stent Price by Type
        4.3.1 Global Next-Generation Drug-Eluting Stent Price by Type (2017-2022)
        4.3.2 Global Next-Generation Drug-Eluting Stent Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Next-Generation Drug-Eluting Stent Sales by Application
        5.1.1 Global Next-Generation Drug-Eluting Stent Historical Sales by Application (2017-2022)
        5.1.2 Global Next-Generation Drug-Eluting Stent Forecasted Sales by Application (2023-2028)
        5.1.3 Global Next-Generation Drug-Eluting Stent Sales Market Share by Application (2017-2028)
    5.2 Global Next-Generation Drug-Eluting Stent Revenue by Application
        5.2.1 Global Next-Generation Drug-Eluting Stent Historical Revenue by Application (2017-2022)
        5.2.2 Global Next-Generation Drug-Eluting Stent Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Next-Generation Drug-Eluting Stent Revenue Market Share by Application (2017-2028)
    5.3 Global Next-Generation Drug-Eluting Stent Price by Application
        5.3.1 Global Next-Generation Drug-Eluting Stent Price by Application (2017-2022)
        5.3.2 Global Next-Generation Drug-Eluting Stent Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Next-Generation Drug-Eluting Stent Market Size by Type
        6.1.1 North America Next-Generation Drug-Eluting Stent Sales by Type (2017-2028)
        6.1.2 North America Next-Generation Drug-Eluting Stent Revenue by Type (2017-2028)
    6.2 North America Next-Generation Drug-Eluting Stent Market Size by Application
        6.2.1 North America Next-Generation Drug-Eluting Stent Sales by Application (2017-2028)
        6.2.2 North America Next-Generation Drug-Eluting Stent Revenue by Application (2017-2028)
    6.3 North America Next-Generation Drug-Eluting Stent Market Size by Country
        6.3.1 North America Next-Generation Drug-Eluting Stent Sales by Country (2017-2028)
        6.3.2 North America Next-Generation Drug-Eluting Stent Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Next-Generation Drug-Eluting Stent Market Size by Type
        7.1.1 Europe Next-Generation Drug-Eluting Stent Sales by Type (2017-2028)
        7.1.2 Europe Next-Generation Drug-Eluting Stent Revenue by Type (2017-2028)
    7.2 Europe Next-Generation Drug-Eluting Stent Market Size by Application
        7.2.1 Europe Next-Generation Drug-Eluting Stent Sales by Application (2017-2028)
        7.2.2 Europe Next-Generation Drug-Eluting Stent Revenue by Application (2017-2028)
    7.3 Europe Next-Generation Drug-Eluting Stent Market Size by Country
        7.3.1 Europe Next-Generation Drug-Eluting Stent Sales by Country (2017-2028)
        7.3.2 Europe Next-Generation Drug-Eluting Stent Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Next-Generation Drug-Eluting Stent Market Size by Type
        8.1.1 Asia Pacific Next-Generation Drug-Eluting Stent Sales by Type (2017-2028)
        8.1.2 Asia Pacific Next-Generation Drug-Eluting Stent Revenue by Type (2017-2028)
    8.2 Asia Pacific Next-Generation Drug-Eluting Stent Market Size by Application
        8.2.1 Asia Pacific Next-Generation Drug-Eluting Stent Sales by Application (2017-2028)
        8.2.2 Asia Pacific Next-Generation Drug-Eluting Stent Revenue by Application (2017-2028)
    8.3 Asia Pacific Next-Generation Drug-Eluting Stent Market Size by Region
        8.3.1 Asia Pacific Next-Generation Drug-Eluting Stent Sales by Region (2017-2028)
        8.3.2 Asia Pacific Next-Generation Drug-Eluting Stent Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Next-Generation Drug-Eluting Stent Market Size by Type
        9.1.1 Latin America Next-Generation Drug-Eluting Stent Sales by Type (2017-2028)
        9.1.2 Latin America Next-Generation Drug-Eluting Stent Revenue by Type (2017-2028)
    9.2 Latin America Next-Generation Drug-Eluting Stent Market Size by Application
        9.2.1 Latin America Next-Generation Drug-Eluting Stent Sales by Application (2017-2028)
        9.2.2 Latin America Next-Generation Drug-Eluting Stent Revenue by Application (2017-2028)
    9.3 Latin America Next-Generation Drug-Eluting Stent Market Size by Country
        9.3.1 Latin America Next-Generation Drug-Eluting Stent Sales by Country (2017-2028)
        9.3.2 Latin America Next-Generation Drug-Eluting Stent Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Next-Generation Drug-Eluting Stent Market Size by Type
        10.1.1 Middle East and Africa Next-Generation Drug-Eluting Stent Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Next-Generation Drug-Eluting Stent Revenue by Type (2017-2028)
    10.2 Middle East and Africa Next-Generation Drug-Eluting Stent Market Size by Application
        10.2.1 Middle East and Africa Next-Generation Drug-Eluting Stent Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Next-Generation Drug-Eluting Stent Revenue by Application (2017-2028)
    10.3 Middle East and Africa Next-Generation Drug-Eluting Stent Market Size by Country
        10.3.1 Middle East and Africa Next-Generation Drug-Eluting Stent Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Next-Generation Drug-Eluting Stent Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Abbott
        11.1.1 Abbott Corporation Information
        11.1.2 Abbott Overview
        11.1.3 Abbott Next-Generation Drug-Eluting Stent Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Abbott Next-Generation Drug-Eluting Stent Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Abbott Recent Developments
    11.2 Biosensors International
        11.2.1 Biosensors International Corporation Information
        11.2.2 Biosensors International Overview
        11.2.3 Biosensors International Next-Generation Drug-Eluting Stent Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Biosensors International Next-Generation Drug-Eluting Stent Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Biosensors International Recent Developments
    11.3 Medtronic
        11.3.1 Medtronic Corporation Information
        11.3.2 Medtronic Overview
        11.3.3 Medtronic Next-Generation Drug-Eluting Stent Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Medtronic Next-Generation Drug-Eluting Stent Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Medtronic Recent Developments
    11.4 Sorin Group
        11.4.1 Sorin Group Corporation Information
        11.4.2 Sorin Group Overview
        11.4.3 Sorin Group Next-Generation Drug-Eluting Stent Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Sorin Group Next-Generation Drug-Eluting Stent Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Sorin Group Recent Developments
    11.5 SMT
        11.5.1 SMT Corporation Information
        11.5.2 SMT Overview
        11.5.3 SMT Next-Generation Drug-Eluting Stent Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 SMT Next-Generation Drug-Eluting Stent Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 SMT Recent Developments
    11.6 Terumo
        11.6.1 Terumo Corporation Information
        11.6.2 Terumo Overview
        11.6.3 Terumo Next-Generation Drug-Eluting Stent Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Terumo Next-Generation Drug-Eluting Stent Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Terumo Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Next-Generation Drug-Eluting Stent Industry Chain Analysis
    12.2 Next-Generation Drug-Eluting Stent Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Next-Generation Drug-Eluting Stent Production Mode & Process
    12.4 Next-Generation Drug-Eluting Stent Sales and Marketing
        12.4.1 Next-Generation Drug-Eluting Stent Sales Channels
        12.4.2 Next-Generation Drug-Eluting Stent Distributors
    12.5 Next-Generation Drug-Eluting Stent Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Next-Generation Drug-Eluting Stent Industry Trends
    13.2 Next-Generation Drug-Eluting Stent Market Drivers
    13.3 Next-Generation Drug-Eluting Stent Market Challenges
    13.4 Next-Generation Drug-Eluting Stent Market Restraints
14 Key Findings in The Global Next-Generation Drug-Eluting Stent Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Next-Generation Drug-Eluting Stent Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Cobalt Chromium
    Table 3. Major Manufacturers of Stainless Steel
    Table 4. Major Manufacturers of Others
    Table 5. Global Next-Generation Drug-Eluting Stent Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Next-Generation Drug-Eluting Stent Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Next-Generation Drug-Eluting Stent Sales by Region (2017-2022) & (K Units)
    Table 8. Global Next-Generation Drug-Eluting Stent Sales Market Share by Region (2017-2022)
    Table 9. Global Next-Generation Drug-Eluting Stent Sales by Region (2023-2028) & (K Units)
    Table 10. Global Next-Generation Drug-Eluting Stent Sales Market Share by Region (2023-2028)
    Table 11. Global Next-Generation Drug-Eluting Stent Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Next-Generation Drug-Eluting Stent Revenue Market Share by Region (2017-2022)
    Table 13. Global Next-Generation Drug-Eluting Stent Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Next-Generation Drug-Eluting Stent Revenue Market Share by Region (2023-2028)
    Table 15. Global Next-Generation Drug-Eluting Stent Sales by Manufacturers (2017-2022) & (K Units)
    Table 16. Global Next-Generation Drug-Eluting Stent Sales Share by Manufacturers (2017-2022)
    Table 17. Global Next-Generation Drug-Eluting Stent Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Next-Generation Drug-Eluting Stent Revenue Share by Manufacturers (2017-2022)
    Table 19. Next-Generation Drug-Eluting Stent Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 20. Global Next-Generation Drug-Eluting Stent Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Next-Generation Drug-Eluting Stent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next-Generation Drug-Eluting Stent as of 2021)
    Table 22. Next-Generation Drug-Eluting Stent Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Next-Generation Drug-Eluting Stent Product Offered
    Table 24. Date of Manufacturers Enter into Next-Generation Drug-Eluting Stent Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Next-Generation Drug-Eluting Stent Sales by Type (2017-2022) & (K Units)
    Table 27. Global Next-Generation Drug-Eluting Stent Sales by Type (2023-2028) & (K Units)
    Table 28. Global Next-Generation Drug-Eluting Stent Sales Share by Type (2017-2022)
    Table 29. Global Next-Generation Drug-Eluting Stent Sales Share by Type (2023-2028)
    Table 30. Global Next-Generation Drug-Eluting Stent Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Next-Generation Drug-Eluting Stent Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Next-Generation Drug-Eluting Stent Revenue Share by Type (2017-2022)
    Table 33. Global Next-Generation Drug-Eluting Stent Revenue Share by Type (2023-2028)
    Table 34. Next-Generation Drug-Eluting Stent Price by Type (2017-2022) & (USD/Unit)
    Table 35. Global Next-Generation Drug-Eluting Stent Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 36. Global Next-Generation Drug-Eluting Stent Sales by Application (2017-2022) & (K Units)
    Table 37. Global Next-Generation Drug-Eluting Stent Sales by Application (2023-2028) & (K Units)
    Table 38. Global Next-Generation Drug-Eluting Stent Sales Share by Application (2017-2022)
    Table 39. Global Next-Generation Drug-Eluting Stent Sales Share by Application (2023-2028)
    Table 40. Global Next-Generation Drug-Eluting Stent Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Next-Generation Drug-Eluting Stent Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Next-Generation Drug-Eluting Stent Revenue Share by Application (2017-2022)
    Table 43. Global Next-Generation Drug-Eluting Stent Revenue Share by Application (2023-2028)
    Table 44. Next-Generation Drug-Eluting Stent Price by Application (2017-2022) & (USD/Unit)
    Table 45. Global Next-Generation Drug-Eluting Stent Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 46. North America Next-Generation Drug-Eluting Stent Sales by Type (2017-2022) & (K Units)
    Table 47. North America Next-Generation Drug-Eluting Stent Sales by Type (2023-2028) & (K Units)
    Table 48. North America Next-Generation Drug-Eluting Stent Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Next-Generation Drug-Eluting Stent Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Next-Generation Drug-Eluting Stent Sales by Application (2017-2022) & (K Units)
    Table 51. North America Next-Generation Drug-Eluting Stent Sales by Application (2023-2028) & (K Units)
    Table 52. North America Next-Generation Drug-Eluting Stent Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Next-Generation Drug-Eluting Stent Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Next-Generation Drug-Eluting Stent Sales by Country (2017-2022) & (K Units)
    Table 55. North America Next-Generation Drug-Eluting Stent Sales by Country (2023-2028) & (K Units)
    Table 56. North America Next-Generation Drug-Eluting Stent Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Next-Generation Drug-Eluting Stent Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Next-Generation Drug-Eluting Stent Sales by Type (2017-2022) & (K Units)
    Table 59. Europe Next-Generation Drug-Eluting Stent Sales by Type (2023-2028) & (K Units)
    Table 60. Europe Next-Generation Drug-Eluting Stent Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Next-Generation Drug-Eluting Stent Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Next-Generation Drug-Eluting Stent Sales by Application (2017-2022) & (K Units)
    Table 63. Europe Next-Generation Drug-Eluting Stent Sales by Application (2023-2028) & (K Units)
    Table 64. Europe Next-Generation Drug-Eluting Stent Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Next-Generation Drug-Eluting Stent Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Next-Generation Drug-Eluting Stent Sales by Country (2017-2022) & (K Units)
    Table 67. Europe Next-Generation Drug-Eluting Stent Sales by Country (2023-2028) & (K Units)
    Table 68. Europe Next-Generation Drug-Eluting Stent Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Next-Generation Drug-Eluting Stent Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Next-Generation Drug-Eluting Stent Sales by Type (2017-2022) & (K Units)
    Table 71. Asia Pacific Next-Generation Drug-Eluting Stent Sales by Type (2023-2028) & (K Units)
    Table 72. Asia Pacific Next-Generation Drug-Eluting Stent Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Next-Generation Drug-Eluting Stent Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Next-Generation Drug-Eluting Stent Sales by Application (2017-2022) & (K Units)
    Table 75. Asia Pacific Next-Generation Drug-Eluting Stent Sales by Application (2023-2028) & (K Units)
    Table 76. Asia Pacific Next-Generation Drug-Eluting Stent Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Next-Generation Drug-Eluting Stent Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Next-Generation Drug-Eluting Stent Sales by Region (2017-2022) & (K Units)
    Table 79. Asia Pacific Next-Generation Drug-Eluting Stent Sales by Region (2023-2028) & (K Units)
    Table 80. Asia Pacific Next-Generation Drug-Eluting Stent Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Next-Generation Drug-Eluting Stent Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Next-Generation Drug-Eluting Stent Sales by Type (2017-2022) & (K Units)
    Table 83. Latin America Next-Generation Drug-Eluting Stent Sales by Type (2023-2028) & (K Units)
    Table 84. Latin America Next-Generation Drug-Eluting Stent Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Next-Generation Drug-Eluting Stent Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Next-Generation Drug-Eluting Stent Sales by Application (2017-2022) & (K Units)
    Table 87. Latin America Next-Generation Drug-Eluting Stent Sales by Application (2023-2028) & (K Units)
    Table 88. Latin America Next-Generation Drug-Eluting Stent Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Next-Generation Drug-Eluting Stent Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Next-Generation Drug-Eluting Stent Sales by Country (2017-2022) & (K Units)
    Table 91. Latin America Next-Generation Drug-Eluting Stent Sales by Country (2023-2028) & (K Units)
    Table 92. Latin America Next-Generation Drug-Eluting Stent Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Next-Generation Drug-Eluting Stent Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Next-Generation Drug-Eluting Stent Sales by Type (2017-2022) & (K Units)
    Table 95. Middle East and Africa Next-Generation Drug-Eluting Stent Sales by Type (2023-2028) & (K Units)
    Table 96. Middle East and Africa Next-Generation Drug-Eluting Stent Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Next-Generation Drug-Eluting Stent Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Next-Generation Drug-Eluting Stent Sales by Application (2017-2022) & (K Units)
    Table 99. Middle East and Africa Next-Generation Drug-Eluting Stent Sales by Application (2023-2028) & (K Units)
    Table 100. Middle East and Africa Next-Generation Drug-Eluting Stent Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Next-Generation Drug-Eluting Stent Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Next-Generation Drug-Eluting Stent Sales by Country (2017-2022) & (K Units)
    Table 103. Middle East and Africa Next-Generation Drug-Eluting Stent Sales by Country (2023-2028) & (K Units)
    Table 104. Middle East and Africa Next-Generation Drug-Eluting Stent Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Next-Generation Drug-Eluting Stent Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Abbott Corporation Information
    Table 107. Abbott Description and Major Businesses
    Table 108. Abbott Next-Generation Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 109. Abbott Next-Generation Drug-Eluting Stent Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Abbott Recent Developments
    Table 111. Biosensors International Corporation Information
    Table 112. Biosensors International Description and Major Businesses
    Table 113. Biosensors International Next-Generation Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 114. Biosensors International Next-Generation Drug-Eluting Stent Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Biosensors International Recent Developments
    Table 116. Medtronic Corporation Information
    Table 117. Medtronic Description and Major Businesses
    Table 118. Medtronic Next-Generation Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 119. Medtronic Next-Generation Drug-Eluting Stent Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Medtronic Recent Developments
    Table 121. Sorin Group Corporation Information
    Table 122. Sorin Group Description and Major Businesses
    Table 123. Sorin Group Next-Generation Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 124. Sorin Group Next-Generation Drug-Eluting Stent Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Sorin Group Recent Developments
    Table 126. SMT Corporation Information
    Table 127. SMT Description and Major Businesses
    Table 128. SMT Next-Generation Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 129. SMT Next-Generation Drug-Eluting Stent Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. SMT Recent Developments
    Table 131. Terumo Corporation Information
    Table 132. Terumo Description and Major Businesses
    Table 133. Terumo Next-Generation Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 134. Terumo Next-Generation Drug-Eluting Stent Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Terumo Recent Developments
    Table 136. Key Raw Materials Lists
    Table 137. Raw Materials Key Suppliers Lists
    Table 138. Next-Generation Drug-Eluting Stent Distributors List
    Table 139. Next-Generation Drug-Eluting Stent Customers List
    Table 140. Next-Generation Drug-Eluting Stent Market Trends
    Table 141. Next-Generation Drug-Eluting Stent Market Drivers
    Table 142. Next-Generation Drug-Eluting Stent Market Challenges
    Table 143. Next-Generation Drug-Eluting Stent Market Restraints
    Table 144. Research Programs/Design for This Report
    Table 145. Key Data Information from Secondary Sources
    Table 146. Key Data Information from Primary Sources
List of Figures
    Figure 1. Next-Generation Drug-Eluting Stent Product Picture
    Figure 3. Global Next-Generation Drug-Eluting Stent Market Share by Type in 2021 & 2028
    Figure 3. Cobalt Chromium Product Picture
    Figure 4. Stainless Steel Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global Next-Generation Drug-Eluting Stent Market Share by Application in 2021 & 2028
    Figure 7. Hospitals
    Figure 8. Clinics
    Figure 9. Ambulatory Surgical Centers
    Figure 10. Next-Generation Drug-Eluting Stent Report Years Considered
    Figure 11. Global Next-Generation Drug-Eluting Stent Sales 2017-2028 (K Units)
    Figure 12. Global Next-Generation Drug-Eluting Stent Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Next-Generation Drug-Eluting Stent Revenue 2017-2028 (US$ Million)
    Figure 14. Global Next-Generation Drug-Eluting Stent Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 15. Global Next-Generation Drug-Eluting Stent Sales Market Share by Region (2017-2022)
    Figure 16. Global Next-Generation Drug-Eluting Stent Sales Market Share by Region (2023-2028)
    Figure 17. North America Next-Generation Drug-Eluting Stent Sales YoY (2017-2028) & (K Units)
    Figure 18. North America Next-Generation Drug-Eluting Stent Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Europe Next-Generation Drug-Eluting Stent Sales YoY (2017-2028) & (K Units)
    Figure 20. Europe Next-Generation Drug-Eluting Stent Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Asia-Pacific Next-Generation Drug-Eluting Stent Sales YoY (2017-2028) & (K Units)
    Figure 22. Asia-Pacific Next-Generation Drug-Eluting Stent Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Latin America Next-Generation Drug-Eluting Stent Sales YoY (2017-2028) & (K Units)
    Figure 24. Latin America Next-Generation Drug-Eluting Stent Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Middle East & Africa Next-Generation Drug-Eluting Stent Sales YoY (2017-2028) & (K Units)
    Figure 26. Middle East & Africa Next-Generation Drug-Eluting Stent Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. The Next-Generation Drug-Eluting Stent Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 28. The Top 5 and 10 Largest Manufacturers of Next-Generation Drug-Eluting Stent in the World: Market Share by Next-Generation Drug-Eluting Stent Revenue in 2021
    Figure 29. Global Next-Generation Drug-Eluting Stent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 30. Global Next-Generation Drug-Eluting Stent Sales Market Share by Type (2017-2028)
    Figure 31. Global Next-Generation Drug-Eluting Stent Revenue Market Share by Type (2017-2028)
    Figure 32. Global Next-Generation Drug-Eluting Stent Sales Market Share by Application (2017-2028)
    Figure 33. Global Next-Generation Drug-Eluting Stent Revenue Market Share by Application (2017-2028)
    Figure 34. North America Next-Generation Drug-Eluting Stent Sales Market Share by Type (2017-2028)
    Figure 35. North America Next-Generation Drug-Eluting Stent Revenue Market Share by Type (2017-2028)
    Figure 36. North America Next-Generation Drug-Eluting Stent Sales Market Share by Application (2017-2028)
    Figure 37. North America Next-Generation Drug-Eluting Stent Revenue Market Share by Application (2017-2028)
    Figure 38. North America Next-Generation Drug-Eluting Stent Sales Share by Country (2017-2028)
    Figure 39. North America Next-Generation Drug-Eluting Stent Revenue Share by Country (2017-2028)
    Figure 40. U.S. Next-Generation Drug-Eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 41. Canada Next-Generation Drug-Eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 42. Europe Next-Generation Drug-Eluting Stent Sales Market Share by Type (2017-2028)
    Figure 43. Europe Next-Generation Drug-Eluting Stent Revenue Market Share by Type (2017-2028)
    Figure 44. Europe Next-Generation Drug-Eluting Stent Sales Market Share by Application (2017-2028)
    Figure 45. Europe Next-Generation Drug-Eluting Stent Revenue Market Share by Application (2017-2028)
    Figure 46. Europe Next-Generation Drug-Eluting Stent Sales Share by Country (2017-2028)
    Figure 47. Europe Next-Generation Drug-Eluting Stent Revenue Share by Country (2017-2028)
    Figure 48. Germany Next-Generation Drug-Eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 49. France Next-Generation Drug-Eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 50. U.K. Next-Generation Drug-Eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 51. Italy Next-Generation Drug-Eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 52. Russia Next-Generation Drug-Eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 53. Asia Pacific Next-Generation Drug-Eluting Stent Sales Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Next-Generation Drug-Eluting Stent Revenue Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Next-Generation Drug-Eluting Stent Sales Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Next-Generation Drug-Eluting Stent Revenue Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Next-Generation Drug-Eluting Stent Sales Share by Region (2017-2028)
    Figure 58. Asia Pacific Next-Generation Drug-Eluting Stent Revenue Share by Region (2017-2028)
    Figure 59. China Next-Generation Drug-Eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 60. Japan Next-Generation Drug-Eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 61. South Korea Next-Generation Drug-Eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 62. India Next-Generation Drug-Eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 63. Australia Next-Generation Drug-Eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 64. Taiwan Next-Generation Drug-Eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 65. Indonesia Next-Generation Drug-Eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 66. Thailand Next-Generation Drug-Eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 67. Malaysia Next-Generation Drug-Eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 68. Philippines Next-Generation Drug-Eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 69. Latin America Next-Generation Drug-Eluting Stent Sales Market Share by Type (2017-2028)
    Figure 70. Latin America Next-Generation Drug-Eluting Stent Revenue Market Share by Type (2017-2028)
    Figure 71. Latin America Next-Generation Drug-Eluting Stent Sales Market Share by Application (2017-2028)
    Figure 72. Latin America Next-Generation Drug-Eluting Stent Revenue Market Share by Application (2017-2028)
    Figure 73. Latin America Next-Generation Drug-Eluting Stent Sales Share by Country (2017-2028)
    Figure 74. Latin America Next-Generation Drug-Eluting Stent Revenue Share by Country (2017-2028)
    Figure 75. Mexico Next-Generation Drug-Eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 76. Brazil Next-Generation Drug-Eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 77. Argentina Next-Generation Drug-Eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 78. Middle East and Africa Next-Generation Drug-Eluting Stent Sales Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Next-Generation Drug-Eluting Stent Revenue Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Next-Generation Drug-Eluting Stent Sales Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Next-Generation Drug-Eluting Stent Revenue Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Next-Generation Drug-Eluting Stent Sales Share by Country (2017-2028)
    Figure 83. Middle East and Africa Next-Generation Drug-Eluting Stent Revenue Share by Country (2017-2028)
    Figure 84. Turkey Next-Generation Drug-Eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 85. Saudi Arabia Next-Generation Drug-Eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 86. UAE Next-Generation Drug-Eluting Stent Revenue (2017-2028) & (US$ Million)
    Figure 87. Next-Generation Drug-Eluting Stent Value Chain
    Figure 88. Next-Generation Drug-Eluting Stent Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed